Kan Lu

6.5k total citations · 1 hit paper
38 papers, 3.4k citations indexed

About

Kan Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kan Lu has authored 38 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Kan Lu's work include Angiogenesis and VEGF in Cancer (6 papers), Cell Adhesion Molecules Research (5 papers) and Luminescence Properties of Advanced Materials (4 papers). Kan Lu is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Cell Adhesion Molecules Research (5 papers) and Luminescence Properties of Advanced Materials (4 papers). Kan Lu collaborates with scholars based in United States, China and Taiwan. Kan Lu's co-authors include Gabriele Bergers, Scott R. VandenBerg, Paul S. Mischel, Timothy F. Cloughesy, Rose Du, Ruth Ganß, Claudia Petritsch, Randall S. Johnson, Emmanuelle Passegué and Zena Werb and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Kan Lu

34 papers receiving 3.3k citations

Hit Papers

HIF1α Induces the Recruitment of Bone Marrow-Derived Vasc... 2008 2026 2014 2020 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
    2008 902 citations Rose Du, Kan Lu et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kan Lu United States 22 1.9k 1.1k 868 774 532 38 3.4k
John D. Hooper Australia 35 1.9k 1.0× 1.1k 1.0× 1.1k 1.2× 817 1.1× 406 0.8× 120 4.1k
William Flavahan United States 19 3.1k 1.7× 1.4k 1.3× 1.0k 1.2× 859 1.1× 591 1.1× 24 4.5k
Donald L. Durden United States 38 3.3k 1.8× 1.0k 0.9× 1.1k 1.3× 776 1.0× 997 1.9× 108 5.3k
Yi‐Fang Ping China 34 1.9k 1.0× 1.2k 1.1× 1.4k 1.6× 621 0.8× 929 1.7× 70 3.7k
Ian F. Dunn United States 19 1.6k 0.9× 671 0.6× 514 0.6× 670 0.9× 458 0.9× 28 3.3k
Gudrun E. Koehl Germany 28 1.9k 1.0× 615 0.6× 1.2k 1.4× 334 0.4× 599 1.1× 44 4.0k
Sang Yong Song South Korea 35 1.6k 0.8× 1.0k 1.0× 1.2k 1.4× 341 0.4× 382 0.7× 138 3.9k
Caroline A. Heckman Finland 31 2.2k 1.2× 662 0.6× 993 1.1× 504 0.7× 495 0.9× 135 3.6k
Sheri L. Holmen United States 28 2.1k 1.1× 450 0.4× 784 0.9× 572 0.7× 401 0.8× 63 3.0k
Naoto Tsuchiya Japan 31 2.6k 1.4× 1.7k 1.6× 787 0.9× 356 0.5× 803 1.5× 72 3.7k

Countries citing papers authored by Kan Lu

Since Specialization
Citations

This map shows the geographic impact of Kan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan Lu more than expected).

Fields of papers citing papers by Kan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan Lu. The network helps show where Kan Lu may publish in the future.

Co-authorship network of co-authors of Kan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Kan Lu. A scholar is included among the top collaborators of Kan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kan Lu. Kan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Kan, Christoph Schmitz, H MORRIS, et al.. (2025). Alveolar and Systemic Immune Mediator Levels Distinguish Rejection vs. Infection in Lung Transplant Recipients With Elevated Plasma Donor-Derived Cell Free DNA Levels. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7438–A7438.
3.
Wu, Jheng‐Yan, et al.. (2025). Liberal vs. restrictive transfusion strategy for acute brain injury: A meta-analysis with trial sequential analysis of randomized clinical trials. Anaesthesia Critical Care & Pain Medicine. 44(5). 101566–101566. 1 indexed citations
4.
Zhang, Qifan, et al.. (2024). Highly efficiency up and down -conversion photoluminescence in Er/Tm/Yb co-doped lutecia-stabilized zirconia single crystals. Journal of Alloys and Compounds. 1008. 176551–176551. 3 indexed citations
5.
Lu, Kan, Cheng‐Yang Hsieh, Daniel Hsiang‐Te Tsai, et al.. (2024). Association between dementia and left atrial appendage occlusion in patients with atrial fibrillation: A TriNetX-based retrospective cohort study with target trial emulation. Heart Rhythm O2. 6(2). 151–158. 1 indexed citations
6.
Zhang, Qifan, Limin Wu, Kan Lu, et al.. (2024). Design, growth and photoluminescence properties of Yb3+:ErSZ and Er3+:YbSZ single crystals excited by 1550 nm and 980 nm lasers. Optical Materials. 157. 116164–116164. 4 indexed citations
7.
Hao, Juan, Yi Xu, Kan Lu, et al.. (2023). Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response inDDC-induced Murine Cholangiopathies Model. Current Molecular Pharmacology. 17. e18761429251911–e18761429251911. 4 indexed citations
8.
Wu, Jian, Kan Lu, Xin Xie, et al.. (2019). miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5. Biochemical and Biophysical Research Communications. 521(4). 984–990. 33 indexed citations
9.
Wen, Chi Pang, Chi‐Hung Liu, Jiann‐Shing Jeng, et al.. (2017). Pre‐stroke physical activity is associated with fewer post‐stroke complications, lower mortality and a better long‐term outcome. European Journal of Neurology. 24(12). 1525–1531. 33 indexed citations
10.
Jahangiri, Arman, Michael De Lay, Liane M. Miller, et al.. (2013). Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance. Clinical Cancer Research. 19(7). 1773–1783. 161 indexed citations
11.
Wu, Jian, et al.. (2013). Urinary TNF-α and NGAL are correlated with the progression of nephropathy in patients with type 2 diabetes. Experimental and Therapeutic Medicine. 6(6). 1482–1488. 31 indexed citations
12.
Fischer, Staci A. & Kan Lu. (2013). Screening of Donor and Recipient in Solid Organ Transplantation. American Journal of Transplantation. 13. 9–21. 88 indexed citations
13.
Lu, Kan, Jeffrey P. Chang, Christine A. Parachoniak, et al.. (2012). VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex. Cancer Cell. 22(1). 21–35. 425 indexed citations
14.
Inge, Landon J., Sonali P. Barwe, Kan Lu, et al.. (2011). Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Experimental Cell Research. 317(6). 838–848. 46 indexed citations
15.
Du, Rose, Kan Lu, Claudia Petritsch, et al.. (2008). HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion. Cancer Cell. 13(3). 206–220. 902 indexed citations breakdown →
16.
Dinca, Eduard B., Kan Lu, Jann N. Sarkaria, et al.. (2008). p53 Small-Molecule Inhibitor Enhances Temozolomide Cytotoxic Activity against Intracranial Glioblastoma Xenografts. Cancer Research. 68(24). 10034–10039. 42 indexed citations
17.
Lu, Kan, Shaojun Zhu, Ederlyn Q. Dia, et al.. (2006). Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells. Cancer Research. 66(16). 7864–7869. 179 indexed citations
18.
19.
Mischel, Paul S., Ruty Mehrian‐Shai, Tao Shi, et al.. (2003). Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene. 22(15). 2361–2373. 207 indexed citations
20.
Lu, Kan, et al.. (1998). In Vitro Methionine Oxidation of Recombinant Human Leptin. Pharmaceutical Research. 15(4). 632–640. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John D. Hooper Breakdown of academic impact, for papers by William Flavahan Breakdown of academic impact, for papers by Donald L. Durden Breakdown of academic impact, for papers by Yi‐Fang Ping Breakdown of academic impact, for papers by Ian F. Dunn Breakdown of academic impact, for papers by Gudrun E. Koehl Breakdown of academic impact, for papers by Sang Yong Song Breakdown of academic impact, for papers by Caroline A. Heckman Breakdown of academic impact, for papers by Sheri L. Holmen Breakdown of academic impact, for papers by Naoto Tsuchiya
Rankless by CCL
2026